Skip to main content
. 2018 Apr 10;9(27):18832–18843. doi: 10.18632/oncotarget.24777

Figure 3. A PcnaK164R mutation renders lymphomas highly sensitive to CsPt treatment.

Figure 3

(A) Representative examples of DDTP or DDTD tumor bearing mice at the beginning (right), and at the end of the CsPt treatment (left). (B) Kaplan – Meier curve of mice carrying DDTP or DDTD tumors. **p = 0.0011 by Mantel-Cox test when comparing DDTP or DDTD tumor bearing mice treated with CsPt. Treated groups received 6 mg/kg CsPt every two weeks, starting from the first bioluminescent signal detection by IVIS.